ClinicalTrials.gg
Sign In

Muscular Disorders, Atrophic clinical trials

The registry lists 56 studies for Muscular Disorders, Atrophic across more than 10 countries. 12 are recruiting or about to start. 24 of them are mainly about Muscular Disorders, Atrophic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 6 narrower conditions too, such as Muscular Dystrophy, Duchenne: 858 studies, 198 open.

Get an email when these change. Save the Muscular Disorders, Atrophic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
26
Recruiting
8
Status unknown
8
Active, not recruiting
5
Terminated
4
Not yet recruiting
2

Phase

Phase 3
7
Phase 2
6
Phase 1
4
Early Phase 1
1

Where

United States
25
Canada
17
United Kingdom
12
Spain
10
Netherlands
9
Belgium
7

Who runs them

McMaster University (5) · Maastricht University Medical Center (5) · Avidity Biosciences, Inc. (3) · PTC Therapeutics (3) · Vertex Pharmaceuticals Incorporated (2) · University of Birmingham (2) · Bispebjerg Hospital (2) · Capricor Inc. (2)

What is being tested here

Drugs under test in Muscular Disorders, Atrophic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Delpacibart zotadirsen111
Ataluren033
Deramiocel012
Leucine002
Protein Supplement001
Urolithin A Supplement001
AOC 1001001
Sevasemten001
Landogrozumab001
BIIB023001

Coming up

2phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 8 Muscular Disorders, Atrophic studies recruiting now, 3 (38%) set no upper age limit and 4 (50%) stop at 75 or younger. 3 (38%) take children under 18. 0 (0%) are for women only and 2 (25%) for men only; 4 (50%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
101 (13%)2 (25%)
185 (63%)6 (75%)
305 (63%)6 (75%)
404 (50%)5 (63%)
504 (50%)4 (50%)
655 (63%)5 (63%)
754 (50%)4 (50%)
853 (38%)3 (38%)

Across all 56 studies, recruiting or not: 70% stop at 75 or younger and 63% at 65; 20% take children; 2% are for women only and 41% for men only; 64% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Muscular Disorders, Atrophic studies take

Of 19 interventional studies with no phase under Muscular Disorders, Atrophic, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo9–25 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 → or search them.